SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
UPLOAD

UPLOAD

Other
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe